MorphoSys AG (NASDAQ:MOR)
| 5.29 Delayed Data As of May 20 |  +0.23 / +4.55%Today’s Change | 4.35 Today|||52-Week Range 22.54 | -43.84% Year-to-Date |
Latest MOR News | Press Releases
No recent news for MorphoSys AG.
Today’s Trading
| Previous close | 5.06 |
| Today’s open | 4.95 |
| Day’s range | 4.95 - 5.31 |
| Volume | 862 |
| Average volume (3 months) | 61,000 |
| Market cap | $714.4M |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -630.65% |
| Earnings growth (this year) | +24.76% |
| Earnings growth (next 5 years) | -23.02% |
| Revenue growth (last year) | -43.17% |
| P/E ratio | NM |
| Price/Sales | 5.93 |
| Price/Book | 2.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NKTRNektar Therapeutics | -0.03 | -0.77% |
| REPLReplimune Group Inc | +0.45 | +3.13% |
| RCKTRocket Pharmaceutica... | +0.72 | +7.21% |
| MRUSMerus NV | +0.56 | +3.45% |
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $212.3M |
| Annual profit (last year) | -$608.1M |
| Net profit margin | -286.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Planegg, Bayern (bavaria) |
Forecasts
